Bariatric (metabolic) surgery isn’t a shortcut; it’s a medical treatment for a chronic disease. The latest indications broadened access because the evidence for health benefits is strong. In 2022, international guidelines from ASMBS/IFSO recommended surgery for anyone with a BMI ≥35 kg/m², regardless of comorbidities, and to consider it from BMI 30–34.9 kg/m² when metabolic disease (like type 2 diabetes) is present. PMC
The main operations in plain language
-
Sleeve gastrectomy (SG): About 70–80% of the stomach is removed. It restricts intake and lowers hunger hormones. It’s popular and effective, but reflux can worsen in some people. PMC
-
Roux-en-Y gastric bypass (RYGB): Makes a small stomach pouch and reroutes the intestine. More powerful for diabetes and reflux than sleeve for many patients. PMC
-
One-anastomosis/mini-gastric bypass (OAGB): A simpler bypass variant; durable weight loss, with similar nutritional risks to RYGB. PMC
-
Duodenal switch/SADI-S: The strongest for weight loss and diabetes remission in severe obesity, but also the highest risk of nutritional deficiency—best for carefully selected patients with excellent follow-up. PMC
Matching the procedure to the person
-
Type 2 diabetes that’s hard to control: Bypass procedures generally beat sleeve for long-term diabetes remission and weight loss. A 2025 Lancet Diabetes & Endocrinology analysis and a 2024 comparative review both favoured RYGB over SG for diabetes control and lipids. thelancet.comPMC
-
Severe reflux or oesophagitis: RYGB typically improves reflux; SG can aggravate it. PMC
-
Very high BMI or multiple metabolic diseases: Duodenal switch or SADI-S deliver the largest average losses, with stricter vitamin/mineral management long-term. PMC
-
You need the lowest pill burden afterwards: SG and RYGB both require lifelong supplements, but malabsorptive operations (DS/SADI-S) demand the most rigorous regimen and monitoring. ASMBS
What to expect from weight loss
Most people lose weight rapidly in the first year and stabilise by 18–24 months. Patient guidance from ASMBS notes typical excess weight loss peaks around 1–2 years and averages about 50% maintained at five years, though results vary by procedure and follow-up. ASMBS
The pre-op work-up (what a good programme checks)
A quality multidisciplinary team—surgeon, physician, dietitian, psychologist—screens for nutritional gaps, reflux, sleep apnoea, diabetes control and readiness for lifelong follow-up. You’ll review procedure choices, expected benefits, risks, and the supplement plan you’ll need to commit to. ASMBS
References
-
2022 ASMBS/IFSO Indications for Metabolic and Bariatric Surgery. PMC
-
Hauge JW et al. Lancet Diabetes & Endocrinology (2025): RYGB vs SG—long-term diabetes remission and weight loss. thelancet.com
-
Alaidaroos O et al. Long-term outcomes SG vs RYGB (2024). PMC
-
ASMBS patient information: expected weight loss after surgery. ASMBS
-
AACE/TOS/ASMBS/OMA/ASA Clinical Practice Guidelines—peri-operative support (2020 update). ASMBS